Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1985 4
1988 1
1989 1
1991 1
1994 1
1995 2
1996 2
1997 2
1998 3
1999 2
2000 1
2001 3
2002 4
2003 1
2004 3
2005 4
2006 9
2007 4
2008 4
2009 5
2010 3
2011 3
2012 1
2013 2
2014 5
2015 7
2016 5
2017 10
2018 3
2019 5
2020 6
2021 11
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Insights in the treatment of congenital nasolacrimal duct obstruction.
Avram E. Avram E. Rom J Ophthalmol. 2017 Apr-Jun;61(2):101-106. doi: 10.22336/rjo.2017.19. Rom J Ophthalmol. 2017. PMID: 29450381 Free PMC article. Review.
Introduction: Congenital nasolacrimal duct obstruction is one of the most common causes of epiphora in newborns and the main cause of this condition is the persistence of Hasner membrane. ...Objective: The objective of this paper is to discuss the efficiency …
Introduction: Congenital nasolacrimal duct obstruction is one of the most common causes of epiphora in newborns and the …
Treatment of Congenital Nasolacrimal Duct Obstruction.
Nelson LB. Nelson LB. J Pediatr Ophthalmol Strabismus. 2016 Sep 1;53(5):270. doi: 10.3928/01913913-20160829-01. J Pediatr Ophthalmol Strabismus. 2016. PMID: 27637019 No abstract available.
Management of congenital nasolacrimal duct obstruction in down syndrome.
Landau Prat D, Tadros S, Revere KE, Katowitz JA, Katowitz WR. Landau Prat D, et al. Eye (Lond). 2023 Mar;37(4):739-743. doi: 10.1038/s41433-022-02047-w. Epub 2022 Apr 4. Eye (Lond). 2023. PMID: 35379922 Free PMC article.
BACKGROUND: Congenital nasolacrimal duct obstruction (CNLDO) is common in Down Syndrome (DS), and more difficult to treat. ...
BACKGROUND: Congenital nasolacrimal duct obstruction (CNLDO) is common in Down Syndrome (DS), and more difficult to tre …
Surgical management of congenital nasolacrimal duct obstruction; one procedure for all versus all procedures for one.
Kashkouli MB, Karimi N, Khademi B. Kashkouli MB, et al. Curr Opin Ophthalmol. 2019 Sep;30(5):364-371. doi: 10.1097/ICU.0000000000000584. Curr Opin Ophthalmol. 2019. PMID: 31219833 Review.
PURPOSE OF REVIEW: After failed conservative management, most clinicians treat congenital nasolacrimal duct obstruction (CNLDO) in a conventional stepwise fashion: starting with probing, then repeat probing, next silicone intubation and/or balloon dilatation, …
PURPOSE OF REVIEW: After failed conservative management, most clinicians treat congenital nasolacrimal duct obstruction …
Infantile orbital abscess: clinical presentation, microbiological profile, and management outcomes.
Tongbram A, Alam S, Agarkar S, Mukherjee B. Tongbram A, et al. Orbit. 2022 Aug;41(4):422-428. doi: 10.1080/01676830.2021.1920040. Epub 2021 May 11. Orbit. 2022. PMID: 33973830
Three patients had upper respiratory tract infection, one had a congenital nasolacrimal duct obstruction, two had sinusitis, and one patient had neonatal sepsis. ...
Three patients had upper respiratory tract infection, one had a congenital nasolacrimal duct obstruction, two had sinus …
Management of congenital nasolacrimal duct obstruction.
Takahashi Y, Kakizaki H, Chan WO, Selva D. Takahashi Y, et al. Acta Ophthalmol. 2010 Aug;88(5):506-13. doi: 10.1111/j.1755-3768.2009.01592.x. Epub 2009 Jul 21. Acta Ophthalmol. 2010. PMID: 19681790 Free article. Review.
Our review aims to provide an update of management protocols for congenital nasolacrimal duct obstruction (CNDO). Although early probing performed before the age of 1 year was traditionally recommended, many reports have since confirmed high frequencies of sp …
Our review aims to provide an update of management protocols for congenital nasolacrimal duct obstruction (CNDO). Altho …
Comparison of treatment for congenital nasolacrimal duct obstruction: a systematic review and meta-analysis.
Lin AE, Chang YC, Lin MY, Tam KW, Shen YD. Lin AE, et al. Can J Ophthalmol. 2016 Feb;51(1):34-40. doi: 10.1016/j.jcjo.2015.10.002. Can J Ophthalmol. 2016. PMID: 26874157 Review.
OBJECTIVE: To conduct a systematic review and meta-analysis of randomized controlled trials comparing the success and complication rates among various congenital nasolacrimal duct obstruction (CNLDO) procedures, intervention times, and tubes types. ...
OBJECTIVE: To conduct a systematic review and meta-analysis of randomized controlled trials comparing the success and complication rates amo …
Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
Yartsev VD, Atkova EL, Ekaterinchev MA. Yartsev VD, et al. Int Ophthalmol. 2023 Sep;43(9):3385-3390. doi: 10.1007/s10792-023-02746-7. Epub 2023 May 18. Int Ophthalmol. 2023. PMID: 37199817
PURPOSE: To investigate the topographic and anatomical features of secondary acquired nasolacrimal duct obstruction (SALDO) due to radioiodine therapy. METHODS: Dacryocystography-computed tomography (DCG-CT) scans of the nasolacrimal ducts in 64 …
PURPOSE: To investigate the topographic and anatomical features of secondary acquired nasolacrimal duct obstruction (SA …
Evaluation and Management of Chemotherapy-Induced Epiphora, Punctal and Canalicular Stenosis, and Nasolacrimal Duct Obstruction.
Mansur C, Pfeiffer ML, Esmaeli B. Mansur C, et al. Ophthalmic Plast Reconstr Surg. 2017 Jan/Feb;33(1):9-12. doi: 10.1097/IOP.0000000000000745. Ophthalmic Plast Reconstr Surg. 2017. PMID: 27429222 Review.
The literature suggests that, in patients who receive weekly docetaxel, silicone stenting at the first sign of recurrent or progressive canalicular stenosis can prevent severe irreversible canalicular stenosis and avoid the need for a conjunctivodacryocystorhinostomy. S-1 and rad …
The literature suggests that, in patients who receive weekly docetaxel, silicone stenting at the first sign of recurrent or progressive cana …
112 results